3rd Quarter - Report

MR. GALEN RESER for PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS)

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSAs and HSAs to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative.

LobbyistCovered position, as disclosed
GALEN J. RESER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Monitor tax reform.

LobbyistCovered position, as disclosed
GALEN J. RESER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Dextromethorphan, Pseudoephedrine restriction issues.

LobbyistCovered position, as disclosed
GALEN J. RESER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.